Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis.
Wanvisa UdomsinprasertJiraphun JittikoonSermsiri SangroongruangsriUsa ChaikledkaewPublished in: Journal of clinical immunology (2020)
Circulating levels of IL-6 and IL-10 might have great potential as biomarkers for the disease severity and mortality in COVID-19 patients.